Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Not yet recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Conditions

Breast Neoplasms 9476Neoplasms 6587Prostatic Neoplasms 4399Colorectal Neoplasms 3977Lung Neoplasms 3642Carcinoma, Non-Small-Cell Lung 3583Pancreatic Neoplasms 2478Carcinoma, Hepatocellular 2411Leukemia, Myeloid, Acute 2265Multiple Myeloma 2120Stomach Neoplasms 2108Neoplasm Metastasis 1911Head and Neck Neoplasms 1869Ovarian Neoplasms 1773Precursor Cell Lymphoblastic Leukemia-Lymphoma 1734Lymphoma 1729Brain Neoplasms 1699Rectal Neoplasms 1676Melanoma 1654Colonic Neoplasms 1629Leukemia 1500Uterine Cervical Neoplasms 1499Recurrence 1485Esophageal Neoplasms 1311Glioblastoma 1307Lymphoma, Non-Hodgkin 1204Leukemia, Lymphocytic, Chronic, B-Cell 1120Squamous Cell Carcinoma of Head and Neck 1109Urinary Bladder Neoplasms 1078Lymphoma, Follicular 1067

Interventions

anlotinib 1Chemotherapy, Adjuvant 1Angiogenesis Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Stereotactic Body Radiation Therapy × Clear all
NCT07334990 2026-01-12

HYPNOCT-4D

Centre Leon Berard

Phase NA Not yet recruiting
25 enrolled

Stereotactic Body Radiation Therapy

NCT05411809 2022-06-09

The ctDNA for Evaluating Whether to Use Adjuvant Therapy After SBRT in Patients With Early Lung Cancer

Peking University Third Hospital

Phase NA Not yet recruiting
180 enrolled

Stereotactic Body Radiation Therapy

NCT04912128 2021-06-03

AnloSBRT

Peking University Third Hospital

Completed
30 enrolled

Stereotactic Body Radiation Therapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡